Network Meta-Analysis of Randomized Trials in Relapsed/Refractory Multiple Myeloma: Relative Efficacy for Patients Who Are Lenalidomide-Refractory

被引：0
|
作者：
Kastritis, Efstathios [1 ]
Harvey, Rebecca [2 ]
Cranmer, Holly [3 ]
Bianco, Martina [4 ]
Fenu, Elisabetta [5 ]
La Porte, Charles [6 ]
Ramasamy, Karthik [7 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Cabourn Stat Ltd, Warrington, England
[3] Cranmer Consultancy Ltd, Sheffield, England
[4] Menarini Ric, Pomezia, Italy
[5] Menarini GmbH, Zurich, Switzerland
[6] Menarini Stemline Therapeut, New York, NY USA
[7] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Evolving Unmet Need in Patients Refractory to Lenalidomide: Overview of the Clinical Trials in Relapsed/Refractory Multiple Myeloma
    Mateos, Maria-Victoria
    Medhekar, Rohan
    Majer, Istvan
    Turgut, Mehmet
    BLOOD, 2020, 136
  • [22] Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple Myeloma: a Meta-analysis of Data from Clinical Trials
    Chen, Runzhe
    Chen, Baoan
    Zhang, Xiaoping
    Gao, Chong
    DISCOVERY MEDICINE, 2016, 22 (121) : 189 - 199
  • [23] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Musuraca, G.
    Lucchesi, A.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Giannini, M. B.
    Di Battista, V.
    Simonetti, G.
    Ferrari, A.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Ghetti, M.
    Napolitano, R.
    Fontana, M. C.
    Padella, A.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S104 - S104
  • [24] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Ferrara, Katia
    Peluso, Ilaria
    Di Perna, Maria
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S255 - S255
  • [25] Efficacy of Isatuximab Combination Regimens in Patients with Relapsed and Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Htut, Thura Win
    Phyu, Ei Moe
    Win, Myint Aung
    Thein, Kyaw Zin
    BLOOD, 2023, 142
  • [26] Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials
    de Moraes, Francisco Cezar Aquino
    Sano, Vitor Kendi Tsuchiya
    Lobo, Artur de Oliveira Macena
    Kelly, Francinny Alves
    Morbach, Victoria
    Pasqualotto, Eric
    Burbano, Rommel Mario Rodriguez
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (04):
  • [27] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2020, 136
  • [28] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Martinelli, G.
    Nappi, D.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Musuraca, G.
    Lucchesi, A.
    Ferrari, A.
    Simonetti, G.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2019, 104 : 71 - 71
  • [29] A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
    Richardson, Paul G.
    Blood, Emily
    Mitsiades, Constantine S.
    Jagannath, Sundar
    Zeldenrust, Steven R.
    Alsina, Melissa
    Schlossman, Robert L.
    Rajkumar, S. Vincent
    Desikan, K. Raman
    Hideshima, Teru
    Munshi, Nikhil C.
    Kelly-Colson, Kathleen
    Doss, Deborah
    McKenney, Mary L.
    Gorelik, Svetlana
    Warren, Diane
    Freeman, Andrea
    Rich, Rebecca
    Wu, Anfang
    Olesnyckyj, Marta
    Wride, Kenton
    Dalton, William S.
    Zeldis, Jerome
    Knight, Robert
    Weller, Edie
    Anderson, Kenneth C.
    BLOOD, 2006, 108 (10) : 3458 - 3464
  • [30] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S310 - S310
12345